Lara Sullivan - Sep 7, 2023 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
President and CEO, Director
Signature
/s/ Pamela Connealy, Attorney-in-Fact for Lara Sullivan
Stock symbol
PYXS
Transactions as of
Sep 7, 2023
Transactions value $
$0
Form type
4
Date filed
9/8/2023, 05:00 PM
Previous filing
Mar 28, 2023
Next filing
Sep 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PYXS Common Stock Award $0 +469K +21.78% $0.00 2.63M Sep 7, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that are fully vested.